Pfizer and Merck Surpass Quarterly Earnings Expectations

Pfizer and Merck have reported profit rises in the first quarter of 2017, signaling a positive year for the life science industry. Pfizer out-earned its projected Q1 profits with sales of breast cancer drug Ibrance and pain reliever Lyrica. Ibrance is expected to see...

Outset Medical Raises Funding for All-In-One Dialysis Device

Outset Medical has raised $76.5 million in a Series C round for its Tablo Hemodialysis System. The all-in-one dialysis device is meant to help patients access lower cost and labor intensive dialysis care. The device eliminates the need for centralized water processing...

Moderna Announces Successful Bird Flu Vaccine Trial

Moderna announced successful Phase 1 clinical trial results this week for this flu-fighting mRNA-1440. The vaccine is intended to combat Influenza Virus H10N8, a strain of bird flu which began commonly appearing in 2014. In this double blind study, Moderna reported...

EU MDR and IVDR to be Published This Friday

EU officials have announced a publication date for the Medical Device Regulations (MDR) and In Vitro Diagnostic Regulations (IVDR) as Friday, May 5 of 2017. These will come into effect twenty days after their publishing on May 25th. Accordingly, the MDR will become...

Two Pore Guys Begin Hand Held Diagnostic Development

Two Pore guys have raised $24.5 million in a Series A Round to begin the development and testing of a hand-help diagnostic tool. The tool is likened to a glucose monitor and will use disposable strips to detect “any kind of molecule.” The company is hoping to broaden...

Allergan Gains Approval for Noninvasive Dry Eye Device

The FDA has given Allergan the green light for its tear-inducing device, TrueTear. The neurostimulating device is a non-invasive and drug free temporary solution to increase tear production. This device is the first of its kind, and creating a breakthrough for...